{"id":"NCT04446312","sponsor":"Braintree Laboratories","briefTitle":"Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy","officialTitle":"A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-13","primaryCompletion":"2021-01-07","completion":"2021-02-05","firstPosted":"2020-06-24","resultsPosted":"2023-10-27","lastUpdate":"2023-10-27"},"enrollment":500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Colonoscopy"],"interventions":[{"type":"DRUG","name":"Bowel Prep","otherNames":[]}],"arms":[{"label":"BLI4900","type":"EXPERIMENTAL"},{"label":"FDA Approved Control","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.","primaryOutcome":{"measure":"Proportion of Subjects With Successful Bowel Preparation","timeFrame":"2 days","effectByArm":[{"arm":"BLI4900","deltaMin":212,"sd":null},{"arm":"FDA Approved Control","deltaMin":211,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":34,"countries":["United States"]},"refs":{"pmids":["37490604"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":227},"commonTop":["Nausea","Vomiting","Headache"]}}